These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12364982)
21. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Tepper CG; Boucher DL; Ryan PE; Ma AH; Xia L; Lee LF; Pretlow TG; Kung HJ Cancer Res; 2002 Nov; 62(22):6606-14. PubMed ID: 12438256 [TBL] [Abstract][Full Text] [Related]
22. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
23. Testosterone effect on the expression of genes that mediate testosterone metabolism and genes that mediate the effect of those metabolites on the prostate. Shidaifat F; Lin YC Life Sci; 2012 Sep; 91(5-6):194-8. PubMed ID: 22820544 [TBL] [Abstract][Full Text] [Related]
24. Androgen receptor immunoreactivity of male rat cervical motor neurons is increased by chronic pharmacologic testosterone treatment. Blanco CE; Davenport T; Wachi S; Goedken T Acta Physiol Pharmacol Bulg; 2001; 26(1-2):7-10. PubMed ID: 11693406 [TBL] [Abstract][Full Text] [Related]
25. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells. Attardi BJ; Burgenson J; Hild SA; Reel JR Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132 [TBL] [Abstract][Full Text] [Related]
26. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359 [TBL] [Abstract][Full Text] [Related]
27. Mathematical model for the androgenic regulation of the prostate in intact and castrated adult male rats. Potter LK; Zager MG; Barton HA Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E952-64. PubMed ID: 16757547 [TBL] [Abstract][Full Text] [Related]
28. Intratesticular androgen levels, androgen receptor localization, and androgen receptor expression in adult rat Sertoli cells. Hill CM; Anway MD; Zirkin BR; Brown TR Biol Reprod; 2004 Oct; 71(4):1348-58. PubMed ID: 15215201 [TBL] [Abstract][Full Text] [Related]
29. Homologous up-regulation of androgen receptor expression by androgen in vascular smooth muscle cells. Ma R; Wu S; Lin Q Horm Res; 2005; 63(1):6-14. PubMed ID: 15564783 [TBL] [Abstract][Full Text] [Related]
30. Regulation of androgen receptor protein and mRNA concentrations by androgens in rat ventral prostate and seminal vesicles and in human hepatoma cells. Shan LX; Rodriguez MC; Jänne OA Mol Endocrinol; 1990 Nov; 4(11):1636-46. PubMed ID: 2177837 [TBL] [Abstract][Full Text] [Related]
31. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404 [TBL] [Abstract][Full Text] [Related]
32. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
33. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer. Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454 [TBL] [Abstract][Full Text] [Related]
34. Androgenic enhancement of betaII-tubulin mRNA in spinal motoneurons following sciatic nerve injury. Brown TJ; Storer P; Oblinger M; Jones KJ Restor Neurol Neurosci; 2001; 18(4):191-8. PubMed ID: 11847442 [TBL] [Abstract][Full Text] [Related]
35. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347 [TBL] [Abstract][Full Text] [Related]
36. In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor. Shao TC; Li H; Eid W; Ittmann M; Unni E; Cunningham GR Prostate; 2003 Sep; 57(1):1-7. PubMed ID: 12886517 [TBL] [Abstract][Full Text] [Related]
37. The combined antiandrogenic effects of five commonly used pesticides. Birkhøj M; Nellemann C; Jarfelt K; Jacobsen H; Andersen HR; Dalgaard M; Vinggaard AM Toxicol Appl Pharmacol; 2004 Nov; 201(1):10-20. PubMed ID: 15519604 [TBL] [Abstract][Full Text] [Related]
38. Deiodinase type 1 activity is expressed in the prostate of pubescent rats and is modulated by thyroid hormones, prolactin and sex hormones. Anguiano B; López A; Delgado G; Romero C; Aceves C J Endocrinol; 2006 Aug; 190(2):363-71. PubMed ID: 16899569 [TBL] [Abstract][Full Text] [Related]
39. Cloning, expression, and regulation by androgens of a putative member of the oxytocinase family of proteins in the rat prostate. Arenas MI; Pérez-Márquez J Prostate; 2002 Nov; 53(3):218-24. PubMed ID: 12386922 [TBL] [Abstract][Full Text] [Related]
40. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]